Navigation Links
AAPS announces 2010 Fellows
Date:11/15/2010

NEW ORLEANS, LA (November 15, 2010) � The American Association of Pharmaceutical Scientists (AAPS) is pleased to announce its 2010 AAPS Fellows. An individual is granted the honor of being named AAPS Fellow after making sustained remarkable scholarly and research contributions to the pharmaceutical sciences such as original articles, scientific presentations at AAPS Annual Meetings, and/or patents.

Joseph P. Balthasar, Ph.D. is Professor of Pharmaceutical Sciences at the State University of New York (SUNY) at Buffalo, and serves as director of their Center for Protein Therapeutics, which utilizes pharmacokinetic/pharmacodynamic analyses to guide the development of new therapies. His current research focuses on the development of drug targeting strategies to improve the selectivity of cancer chemotherapy and on the development of new immunotherapies for the treatment of humoral autoimmune diseases.

Reina Bendayan, Pharm.D. is Associate Dean and a professor in the Department of Pharmaceutical Sciences at the University of Toronto. She has made significant contributions to the field of anti-HIV drug distribution in several compartments of the brain. Her group was one of the first to demonstrate that specific proteins localized in the brain can play a significant role in the permeability of these drugs at primary sites of infection in the Central Nervous System and contribute to antiviral drug resistance.

Panayiotis Constantinides, Ph.D. is the Founder and Principal of Biopharmaceutical & Drug Delivery Consulting, LLC. He has more than 20 years of experience in pharmaceutical research and development with diverse molecules, delivery technologies, and disease indications that span from start-up companies to multinational pharmaceutical organizations. He has made significant contributions in the areas of drug delivery and formulation development of small molecules and macromolecules particularly with lipid-ba
'/>"/>

Contact: Joseph Catapano
catapanoj@aaps.org
703-248-4772
American Association of Pharmaceutical Scientists
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Elsevier announces new partnership with CCS to publish the Canadian Journal of Cardiology
2. Genomic Systems announces moratorium on studying and treating terminal cancer has ended
3. MJFF announces over $10 million in funding for clinical and pre-clinical PD research
4. ESC announces new initiatives for workplace heart health programs
5. ASTRO announces 2010 Annual Meeting awards
6. CRF announces featured clinical trials to be presented at TCT 2010
7. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
8. ASP announces 2010 T. Franklin Williams Scholars
9. Feng Shui Expert Practitioner and Analyst Angel de Para Announces Classical Feng Shui Practitioner Workshop in New York City.
10. Lifeloc supports workplace breath alcohol testing and announces new robust solution, the EV30T
11. QualEDIx Announces the Launch of the Nation's Only Managed Service Model for HIPAA 5010 and ICD-10 Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... in multitasking and ways to train it have been ... universitaire de griatrie de Montral and the University of ... the effectiveness of this training. Cooking while having a ... driving while listening to a radio show ... Unfortunately, it decreases with age, which makes it harder ...
(Date:8/19/2014)... August 20, 2014 Recently, iFitDress.com,a leading ... outfits, has unveiled its new collection of pewter ... to expand the company’s global market. Each item is ... the company’s senior spokesman, customers that have specific requirements ... iFitDress.com. Now, all the brand new items are offered ...
(Date:8/19/2014)... -- Lupus and other rheumatic diseases can cause ... can delay a correct diagnosis for months, a ... can also cause these types of symptoms, according ... in Maywood, Ill. Rheumatic disorders include autoimmune and ... such as lupus, systemic vasculitis and ankylosing spondylitis. ...
(Date:8/19/2014)... from Glasgow where he helped distribute thousands of The ... 23 – August 6), Pete Dwan is a man with ... for his work cannot be overstated. , According to UK ... A drugs within the last year. And that doesn’t take ... to be “legal highs” until June 2014, when the UK ...
(Date:8/19/2014)... the longtime standard treatment for atrial fibrillation, is ... drug marketplace including dabigatran, rivaroxaban, and apixaban. A ... novel oral anticoagulants (NOACs) into clinical practice. By ... anticoagulant prescriptions yet this represents 98% of total ... The American Journal of Medicine . , Atrial ...
Breaking Medicine News(10 mins):Health News:Targeted brain training may help you multitask better 2Health News:Discounted Pewter Evening Dresses For 2014 Unveiled By Company iFitDress.com 2Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:British Scientologist on a Mission to Save Youth from Drug Abuse 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 3
... Oct. 15 Impelsys , a global ... American Academy of Pediatrics (AAP), a ... solidified its e-book strategy with iPublishCentral , ... 350 publishers worldwide. Launching in early 2010, AAP will ...
... DEERFIELD, Ill., October 14, 2009 A study, published ... showed that a greater percentage of patients with type ... (pioglitazone HCl and metformin HCl) as initial therapy reached ... percent compared to either component alone. Safety and tolerability ...
... at reducing the risk of heart attacks and heart ... new report from the Institute of Medicine. The ... secondhand smoke boosts nonsmokers, risk for heart problems, adding ... could lead to a heart attack is compelling. ...
... Program Seeks Adult Athletes to Go the Extra Mile to ... Teen and pre-teen girls face peer pressure, cultural stereotypes ... impact on their futures. That is why former Ironman ... prevention program that prepares girls for a lifetime of self-respect ...
... DIEGO, Oct. 15 Cardium Therapeutics (NYSE Amex: CXM ... to selected investors for aggregate gross proceeds of $6.0 million. ... was filed by Cardium Therapeutics with the Securities and Exchange ... August 15, 2007. Details concerning the terms of the ...
... tradition of capturing celebrity in photograph with 2009 Christmas ... Lung Association has brought back a time-honored tradition this ... a photograph with the 2009 Christmas Seal. This ... distinguished list of celebrities and entertainers who have served ...
Cached Medicine News:Health News:Leading Society Publisher, American Academy of Pediatrics, Chooses iPublishCentral to Launch e-Book Strategy 2Health News:Leading Society Publisher, American Academy of Pediatrics, Chooses iPublishCentral to Launch e-Book Strategy 3Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 2Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 3Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 4Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 5Health News:Smoking bans reduce the risk of heart attacks associated with secondhand smoke 2Health News:Girls on the Run Inspires Girls to Recognize and Achieve Their Potential Through the Power of Running 2Health News:Girls on the Run Inspires Girls to Recognize and Achieve Their Potential Through the Power of Running 3Health News:Cardium Announces $6.0 Million Registered Direct Offering 2Health News:Cardium Announces $6.0 Million Registered Direct Offering 3Health News:S. Epatha Merkerson Lends Star Power to Support the American Lung Association's Christmas Seals Campaign as Celebrity Chairperson 2
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 ... the "Pharmaceutical Contract Manufacturing - Global Strategic Business ... This report analyzes the worldwide markets for Pharmaceutical Contract ... Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms ... (Syrups, Suspensions, Gels, Creams & Ointments). The ...
(Date:8/19/2014)... , Aug. 19, 2014 Research and Markets ... by Type of Material, by Technology, by Application & by ... their offering. The demand for membranes is ... driving the market to $29.31 billion Membrane technology ... applications, such as water filtration and kidney dialysis. In modern ...
(Date:8/19/2014)... According to Kalorama Information, electronic medical records ... Data in healthcare a reality, and this a factor ... American Recovery and Reinvestment Act, the U.S. government dedicated ... penalties will start applying soon for use of paper ... study of the EMR industry, EMR 2014: The ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
... / Ker Accuref K 9001 ... LCD color monitor. 3 step ... 2.3 mm Minimum pupil diameter ... adjuster. Auto start function. Kerato-Peripheral ...
... Suresight is the child-friendly, portable ... children and adults. It can perform ... inches (35 cm) away even through ... flashing lights and sounds engage the ...
Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment is a multiple dose anti-infective steroid combination in sterile ointment form for topical applications....
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: